Coronavirus Update: Novavax's $384m Is CEPI’s Biggest Vaccine Funding
Plus: Non-Coronavirus Trials Need To Re-Start, Says UK Sector
Executive Summary
Pioneer of nanoparticle vaccine technology is latest to get financial backing from the foundation.